Odyssey Therapeutics, Inc. ODTX

Set alert

21.57 USD +2.04 (+10.45%)

At closeNov 3, 2026, 4:01 PM EST

21.57 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

19.70 Day range 21.77

15.10 52-week range 29.05

Held by insiders 6.19%

Held by institutions 83.33%

Float held by institutions 88.83%

Institutions 73

Top institutional holders
Holder	% held	Shares	Value	Reported
FMR, LLC	10.78%	5,179,262	111.72M	Jun 29, 2026
SR One Capital Management, LP	7.90%	3,794,883	81.86M	Jun 29, 2026
TPG GP A, LLC	7.68%	3,690,146	79.60M	Jun 29, 2026
Lightspeed Management Company, L.L.C.	7.51%	3,608,443	77.83M	Jun 29, 2026
Orbimed Advisors LLC.	6.24%	3,001,198	64.74M	Jun 29, 2026
Sanofi	4.14%	1,991,918	42.97M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund	2.30%	1,104,234	23.82M	Aug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	1.11%	531,096	11.46M	Jun 29, 2026
iShares Trust-iShares Russell 2000 ETF	0.88%	424,684	9.16M	Sep 29, 2026
Fidelity Select Portfolios-Select Biotechnology Portfolio	0.71%	340,700	7.35M	Aug 30, 2026
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund	0.64%	308,862	6.66M	Aug 30, 2026
Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund	0.55%	266,600	5.75M	Aug 30, 2026

ODTX insiders
Insider	Relation	Latest transaction	Date	Shares held
CHU SHELLEY	Director	Purchase	May 10, 2026	11,111
DIMENSION CAPITAL II, L.P.	Beneficial Owner of more than 10% of a Class of Security	Purchase	May 7, 2026	0
GLICK GARY D. PH.D.	Chief Executive Officer	Conversion of Exercise of derivative security	May 10, 2026	415,973
HAAS JASON	Chief Financial Officer	Purchase	May 7, 2026	62,908
LEIDEN JEFFREY M	Director	Conversion of Exercise of derivative security	May 10, 2026	0
LI NAN LN	Director	Purchase	May 10, 2026	0

Held by funds